If you are at #ASCO24 be sure to check out some amazing research on ctDNA by Michael LaPelusa, MD MD Anderson Cancer Center

Important finding #ASCO24: “Association between circulating tumor DNA and recurrence-free survival in patients with resected stage III melanoma: An exploratory analysis of SWOG Cancer Research Network S1404”! Join the poster discussion on June 1st, 1:30 PM – 4:30 PM CDT. More: buff.ly/4dXGXR1

Be sure to check out Dr. Kaysia Ludford present 3-year follow up data in patients with locally advanced dMMR/MSI-H solid tumors treated with pembrolizumab! MD Anderson Cancer Center ESMO - Eur. Oncology #ESMO24

My last PhD project on epigenetic-treatment-induced novel antigens in glioblastoma is out. It was a privilege to work with the co-first authors, joshhjang, Nakul Shah, and Yonghao Liang, and mentors, Albert H. Kim and Ting Wang. Please read for more: nature.com/articles/s4158….

Our Dr. Xiuning Le MD PhD presents a key update for patients with HER2 positive NSCLC from the phase 1/2 SOHO-01 study. BAY 2927088 -Oral reversible TKI -ORR 72% (90% in YMVA) -mDOR 8.7 mos -mPFS 7.5 mos -AE: 25% grade 3+ diarrhea #WCLC24 #LCSM OncoAlert

Terrific list of ADC data to be presented at #ESMO24 Most abstracts already available Some showing impressive response rates in hard-to-treat cancers 👇

Thrilled to share my paper! 🙌science.org/doi/10.1126/sc… It was an incredible experience working and exploring such a fascinating story. Huge thanks all co-authors, they r amazing ppl, and everyone in the Zon Lab Dr. Len Zon for all their support both in and out of the lab! 😍

Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 🔎POCHI trial 👉ORR 74%, DRC 100%, 5 CR 👉12-mo PFS rate 51% 👉2-yr OS rate 80% 👉AEs ≥3 70% 🧐IMMUNOSCORE and TuLIS score (18% of pts) to select ICI in mCRC? ESMO - Eur. Oncology #ESMOAmbassadors

New study in Nature Medicine from Scott Kopetz MD Anderson Cancer Center and colleagues Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial nature.com/articles/s4159… The putative genomic mechanisms of resistance (on ctDNA) illustrated below

Stem cells reverse woman’s diabetes — a world first go.nature.com/3N2FOf2

Congratulations Nazli Dizman! Very proud of you🤩 MD Anderson Cancer Center

I am happy to share the latest paper from Goswami_Lab in Nature Immunology. We showed the integration of metabolic & epigenetic pathways regulating CD8 T cell mediated anti tumor immunity via histone lactylation. ⁦Deblina Raychaudhuri⁩⁦@RaiPratishtha⁩⁦MD Anderson Cancer Center⁩

🎉Immensely excited and proud to share with you our recent paper "Guide to Understanding and Supporting #InternationalMedicalGraduates in #Hematology #Oncology" with gratitude to my co-first author Ziad Bakouny, MD, MSc, senior authors Toni Choueiri, MD #DrAlfredLee, and other world-renowned